Works by Stadtmauer, Edward A.

Results: 86
    1
    2

    Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.

    Published in:
    2020
    By:
    • Foss, Francine M.;
    • Wang, Xin Victoria;
    • Luger, Selina M.;
    • Jegede, Opeyemi;
    • Miller, Kenneth B.;
    • Stadtmauer, Edward A.;
    • Whiteside, Theresa L.;
    • Avigan, David E.;
    • Gascoyne, Randall D.;
    • Arber, Daniel;
    • Wagner, Henry;
    • Strair, Roger K.;
    • Hogan, William J.;
    • Sprague, Kellie A.;
    • Lazarus, Hillard M.;
    • Litzow, Mark R.;
    • Tallman, Martin S.;
    • Horning, Sandra J.
    Publication type:
    journal article
    3
    4
    5

    Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide.

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 8, p. 1925, doi. 10.1080/10428194.2022.2042686
    By:
    • Freyer, Craig W.;
    • Carulli, Alison;
    • Gier, Shannon;
    • Ganetsky, Alex;
    • Timlin, Colleen;
    • Schuster, Mindy;
    • Babushok, Daria;
    • Frey, Noelle V.;
    • Gill, Saar I.;
    • Hexner, Elizabeth O.;
    • Luger, Selina M.;
    • Mangan, James K.;
    • Martin, Mary Ellen;
    • McCurdy, Shannon R.;
    • Perl, Alexander E.;
    • Porter, David L.;
    • Pratz, Keith;
    • Smith, Jacqueline;
    • Stadtmauer, Edward A.;
    • Loren, Alison W.
    Publication type:
    Article
    6

    Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 12, p. 3320, doi. 10.3109/10428194.2015.1030641
    By:
    • Niesvizky, Ruben;
    • Badros, Ashraf Z.;
    • Costa, Luciano J.;
    • Ely, Scott A.;
    • Singhal, Seema B.;
    • Stadtmauer, Edward A.;
    • Haideri, Nisreen A.;
    • Yacoub, Abdulraheem;
    • Hess, Georg;
    • Lentzsch, Suzanne;
    • Spicka, Ivan;
    • Chanan-Khan, Asher A.;
    • Raab, Marc S.;
    • Tarantolo, Stefano;
    • Vij, Ravi;
    • Zonder, Jeffrey A.;
    • Huang, Xiangao;
    • Jayabalan, David;
    • Di Liberto, Maurizio;
    • Huang, Xin
    Publication type:
    Article
    7

    A pilot trial of quantitative Epstein-Barr virus polymerase chain reaction in patients undergoing treatment for their malignancy: potential use of Epstein-Barr virus polymerase chain reaction in multiple cancer types.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 5, p. 1530, doi. 10.3109/10428194.2014.963577
    By:
    • Tsai, Donald E.;
    • Luskin, Marlise R.;
    • Kremer, Brandon E.;
    • Chung, Albert K.;
    • Arnoldi, Sharon;
    • Paralkar, Vikram R.;
    • Nasta, Sunita D.;
    • Stadtmauer, Edward A.;
    • Schuster, Stephen J.;
    • Xavier, Marin
    Publication type:
    Article
    8
    9

    Real‐world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 8, p. 1254, doi. 10.1002/ajh.26991
    By:
    • Matthews, Andrew H.;
    • Perl, Alexander E.;
    • Luger, Selina M.;
    • Gill, Saar I.;
    • Lai, Catherine;
    • Porter, David L.;
    • Skuli, Sarah;
    • Bruno, Ximena Jordan;
    • Carroll, Martin P.;
    • Freyer, Craig W.;
    • Carulli, Alison;
    • Babushok, Daria V.;
    • Frey, Noelle V.;
    • Hexner, Elizabeth O.;
    • Martin, Mary Ellen;
    • McCurdy, Shannon R.;
    • Stadtmauer, Edward A.;
    • Loren, Alison W.;
    • Paralkar, Vikram R.;
    • Maillard, Ivan P.
    Publication type:
    Article
    10

    Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 140, doi. 10.1002/ajh.26596
    By:
    • D'Souza, Anita;
    • Brazauskas, Ruta;
    • Stadtmauer, Edward A.;
    • Pasquini, Marcelo C.;
    • Hari, Parameswaran;
    • Bashey, Asad;
    • Callander, Natalie;
    • Devine, Steven;
    • Efebera, Yvonne;
    • Ganguly, Siddhartha;
    • Gasparetto, Cristina;
    • Geller, Nancy;
    • Horowitz, Mary M.;
    • Koreth, John;
    • Landau, Heather;
    • Brunstein, Claudio;
    • McCarthy, Philip;
    • Qazilbash, Muzaffar H.;
    • Giralt, Sergio;
    • Krishnan, Amrita
    Publication type:
    Article
    11

    Risk of invasive fungal infections in patients with high‐risk MDS and AML receiving hypomethylating agents.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 7, p. 792, doi. 10.1002/ajh.25808
    By:
    • Kim, Gee Youn (Geeny);
    • Burns, Jonathan;
    • Freyer, Craig W.;
    • Hamilton, Keith W.;
    • Frey, Noelle V.;
    • Gill, Saar I.;
    • Hexner, Elizabeth O.;
    • Luger, Selina M.;
    • Mangan, James K.;
    • Martin, Mary E.;
    • McCurdy, Shannon R.;
    • Perl, Alexander E.;
    • Porter, David L.;
    • Schuster, Mindy G.;
    • Stadtmauer, Edward A.;
    • Loren, Alison W.
    Publication type:
    Article
    12
    13
    14
    15
    16

    Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 5, p. 453, doi. 10.1002/ajh.24303
    By:
    • Hexner, Elizabeth O.;
    • Luger, Selina M.;
    • Reshef, Ran;
    • Jeschke, Grace R.;
    • Mangan, James K.;
    • Frey, Noelle V.;
    • Frank, Dale M.;
    • Richman, Lee P.;
    • Vonderheide, Robert H.;
    • Aqui, Nicole A.;
    • Rosenbach, Misha;
    • Zhang, Yi;
    • Chew, Anne;
    • Loren, Alison W.;
    • Stadtmauer, Edward A.;
    • Levine, Bruce L.;
    • June, Carl H.;
    • Emerson, Stephen G.;
    • Porter, David L.
    Publication type:
    Article
    17
    18

    Safety and efficacy of upfront plerixafor + G-CSF versus placebo + G-CSF for mobilization of CD34<sup>+</sup> hematopoietic progenitor cells in patients ≥60 and <60 years of age with non-Hodgkin's lymphoma or multiple myeloma.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 12, p. 1017, doi. 10.1002/ajh.23561
    By:
    • Micallef, Ivana N.;
    • Stiff, Patrick J.;
    • Stadtmauer, Edward A.;
    • Bolwell, Brian J.;
    • Nademanee, Auayporn P.;
    • Maziarz, Richard T.;
    • Partisano, Angela M.;
    • Marulkar, Sachin;
    • DiPersio, John F.
    Publication type:
    Article
    19
    20
    21

    OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S9, doi. 10.1016/S2152-2650(21)02087-5
    By:
    • Lonial, Sagar;
    • Richardson, Paul G.;
    • Popat, Rakesh;
    • Stadtmauer, Edward A.;
    • Larsen, Jeremy T.;
    • Oriol, A.;
    • Knop, Stefan;
    • Jagannath, Sundar;
    • Cook, Gordon;
    • Badros, Ashraf Z.;
    • Rodríguez-Otero, Paula;
    • Siegel, David S.;
    • Tuong Vi Nguyen;
    • Micco, Antonia Di;
    • Amin, Alpesh;
    • Min Chen;
    • Kueenburg, Elisabeth;
    • van de Donk, Niels W.C.J.
    Publication type:
    Article
    22
    23
    24
    25

    Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e138, doi. 10.1016/j.clml.2017.03.250
    By:
    • Qazilbash, Muzaffar;
    • Stadtmauer, Edward;
    • Baladandayuthapani, Veera;
    • Tross, Beryl;
    • Honhar, Medhavi;
    • Cha, Soung-chul;
    • Kim, Kunhwa;
    • Rao, Sheeta;
    • Popescu, Michael;
    • Shah, Nina;
    • Bashir, Qaiser;
    • Patel, Krina;
    • Shpall, Elizabeth;
    • Weber, Donna;
    • Thomas, Sheeba;
    • Shah, Jatin;
    • Orlowski, Robert;
    • Kerr, Naseem;
    • Garfall, Alfred;
    • Cohen, Adam
    Publication type:
    Article
    26

    Overall Survival (OS) and Progression-Free Survival (PFS) Adjusted for Treatment Crossover in the CALGB/ECOG 100104 (Alliance) Study of Lenalidomide (LEN) Versus Placebo (PBO) Maintenance After Stem Cell Transplant (SCT) for Patients With Newly Diagnosed Multiple Myeloma

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e135, doi. 10.1016/j.clml.2017.03.244
    By:
    • McCarthy, Philip;
    • Holstein, Sarah;
    • Jung, Sin-Ho;
    • Cooper, Miranda;
    • Gibson, Craig J.;
    • Stadtmauer, Edward;
    • Winograd, Benjamin;
    • Richardson, Paul
    Publication type:
    Article
    27
    28

    Identifying professional education gaps and barriers in multiple myeloma patient care: findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee.

    Published in:
    2014
    By:
    • Raje, Noopur;
    • Faiman, Beth;
    • Harvey, R. Donald;
    • Kurtin, Sandra E.;
    • Lonial, Sagar;
    • Kumar, Shaji K.;
    • Cohen, Adam D.;
    • Conde, Miguel A.;
    • Giralt, Sergio A.;
    • Recine, Marie Sabo;
    • Tombler, Eugene R.;
    • Stadtmauer, Edward;
    • Jagannath, Sundar;
    • Anderson, Kenneth C.;
    • Managing Myeloma Continuing Education Initiative Advisory Group
    Publication type:
    journal article
    29
    30

    Effects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and Dexamethasone.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 38, doi. 10.3816/CLML.2010.n.120
    By:
    • San-Miguel, Jesús F.;
    • Dimopoulos, Meletios A.;
    • Stadtmauer, Edward A.;
    • Rajkumar, S. Vincent;
    • Siegel, David;
    • Bravo, Marie-Laure;
    • Olesnyckyj, Marta;
    • Knight, Robert D.;
    • Zeldis, Jerome B.;
    • Harousseau, Jean-Luc;
    • Weber, Donna M.
    Publication type:
    Article
    31
    32

    Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?

    Published in:
    British Journal of Haematology, 2022, v. 197, n. 3, p. 326, doi. 10.1111/bjh.18108
    By:
    • Abou‐Ismail, Mouhamed Yazan;
    • Fraser, Raphael;
    • Allbee‐Johnson, Mariam;
    • Metheny, Leland;
    • Ravi, Gayathri;
    • Ahn, Kwang Woo;
    • Bhatt, Neel S.;
    • Lazarus, Hillard M.;
    • de Lima, Marcos;
    • El Jurdy, Najla;
    • Hematti, Peiman;
    • Beitinjaneh, Amer M.;
    • Nishihori, Taiga;
    • Badawy, Sherif M.;
    • Sharma, Akshay;
    • Pasquini, Marcelo C.;
    • Savani, Bipin N.;
    • Sorror, Mohamed L.;
    • Stadtmauer, Edward A.;
    • Chhabra, Saurabh
    Publication type:
    Article
    33
    34
    35

    Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer.

    Published in:
    1999
    By:
    • Rowlings, Philip A.;
    • Williams, Stephanie F.;
    • Antman, Karen H.;
    • Fields, Karen K.;
    • Fay, Joseph W.;
    • Reed, Elizabeth;
    • Pelz, Corey J.;
    • Klein, John P.;
    • Sobocinski, Kathleen A.;
    • Kennedy, M. John;
    • Freytes, Cesar O.;
    • McCarthy Jr., Philip L.;
    • Herzig, Roger H.;
    • Stadtmauer, Edward A.;
    • Lazarus, Hillard M.;
    • Pecora, Andrew L.;
    • Bitran, Jacob D.;
    • Wolff, Steven N.;
    • Gale, Robert Peter;
    • Armitage, James O.
    Publication type:
    journal article
    36

    Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.

    Published in:
    European Journal of Haematology, 2009, v. 82, n. 6, p. 426, doi. 10.1111/j.1600-0609.2009.01257.x
    By:
    • Stadtmauer, Edward A.;
    • Weber, Donna M.;
    • Niesvizky, Ruben;
    • Belch, Andrew;
    • Prince, Miles H.;
    • San Miguel, Jesús F.;
    • Facon, Thierry;
    • Olesnyckyj, Marta;
    • Yu, Zhinuan;
    • Zeldis, Jerome B.;
    • Knight, Robert D.;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    37
    38
    39
    40
    41
    42

    NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.

    Published in:
    Nature Medicine, 2015, v. 21, n. 8, p. 914, doi. 10.1038/nm.3910
    By:
    • Rapoport, Aaron P;
    • Stadtmauer, Edward A;
    • Binder-Scholl, Gwendolyn K;
    • Goloubeva, Olga;
    • Vogl, Dan T;
    • Lacey, Simon F;
    • Badros, Ashraf Z;
    • Garfall, Alfred;
    • Weiss, Brendan;
    • Finklestein, Jeffrey;
    • Kulikovskaya, Irina;
    • Sinha, Sanjoy K;
    • Kronsberg, Shari;
    • Gupta, Minnal;
    • Bond, Sarah;
    • Melchiori, Luca;
    • Brewer, Joanna E;
    • Bennett, Alan D;
    • Gerry, Andrew B;
    • Pumphrey, Nicholas J
    Publication type:
    Article
    43

    Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer.

    Published in:
    Nature Medicine, 2005, v. 11, n. 11, p. 1230, doi. 10.1038/nm1310
    By:
    • Rapoport, Aaron P.;
    • Stadtmauer, Edward A.;
    • Aqui, Nicole;
    • Badros, Ashraf;
    • Cotte, Julio;
    • Chrisley, Lisa;
    • Veloso, Elizabeth;
    • Zhaohui Zheng;
    • Westphal, Sandra;
    • Mair, Rebecca;
    • Chi, Nina;
    • Ratterree, Bashi;
    • Pochran, Mary Francis;
    • Natt, Sabrina;
    • Hinkle, Joanne;
    • Sickles, Cheryl;
    • Sohal, Ambika;
    • Ruehle, Kathleen;
    • Lynch, Christian;
    • Lei Zhang
    Publication type:
    Article
    44

    Danazol treatment of myelodysplastic syndromes.

    Published in:
    British Journal of Haematology, 1991, v. 77, n. 4, p. 502, doi. 10.1111/j.1365-2141.1991.tb08617.x
    By:
    • Stadtmauer, Edward A.;
    • Cassileth, Peter A.;
    • Edelstein, Marian;
    • Abrahm, Janet;
    • Schreiber, Alan D.;
    • Nowell, Peter C.;
    • Cines, Douglas B.
    Publication type:
    Article
    45
    46

    Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant.

    Published in:
    Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 892, doi. 10.1177/10781552221080710
    By:
    • Hatch, Rachel V.;
    • Freyer, Craig W.;
    • Carulli, Alison;
    • Redline, Gretchen;
    • Babushok, Daria V.;
    • Frey, Noelle V.;
    • Gill, Saar I.;
    • Hexner, Elizabeth O.;
    • Luger, Selina M.;
    • Martin, Mary Ellen;
    • McCurdy, Shannon R.;
    • Perl, Alexander E.;
    • Porter, David L.;
    • Pratz, Keith W.;
    • Stadtmauer, Edward A.;
    • Loren, Alison W.
    Publication type:
    Article
    47
    48

    Progressive multifocal leukoencephalopathy in multiple myeloma.

    Published in:
    European Journal of Haematology, 2023, v. 110, n. 3, p. 322, doi. 10.1111/ejh.13909
    By:
    • Hoeynck, Brian W.;
    • Cohen, Adam D.;
    • Stadtmauer, Edward A.;
    • Susanibar‐Adaniya, Sandra P.;
    • Vogl, Dan T.;
    • Waxman, Adam J.;
    • Bardsley, Mark;
    • Le, Samantha;
    • LaMaestra, Lexis;
    • Garfall, Alfred L.
    Publication type:
    Article
    49

    Radioimmunotherapy of Non-Hodgkin's Lymphoma with <sup>90</sup>Y-DOTA Humanized Anti-CD22 IgG (<sup>90</sup>Y-Epratuzumab): Do Tumor Targeting and Dosimetry Predict Therapeutic Response?

    Published in:
    Journal of Nuclear Medicine, 2003, v. 44, n. 12, p. 2000
    By:
    • Sharkey, Robert M.;
    • Brenner, Arnold;
    • Burton, Jack;
    • Hajjar, George;
    • Toder, Stephen P.;
    • Alavi, Abass;
    • Matthies, Alexander;
    • Tsai, Donald E.;
    • Schuster, Stephen J.;
    • Stadtmauer, Edward A.;
    • Czuczman, Myron S.;
    • Lamonica, Dominick;
    • Kraeber-Bodere, Françoise;
    • Mahe, Beatrice;
    • Chatal, Jean-François;
    • Rogatko, André;
    • Mardirrosian, George;
    • Goldenberg, David M.
    Publication type:
    Article
    50